Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Giovanni Triolo, Andre Beaulieu, Josef Rovensky, Andre Beaulieu, Rieke Alten, Cesar Ramos-Remus, Thasia Woodworth, Josef S Smolen, Andrea Rubbert-Roth, Emma Alecock

    Research output: Contribution to journalArticlepeer-review

    1072 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)987-997
    JournalThe Lancet
    Volume371
    Publication statusPublished - 2008

    All Science Journal Classification (ASJC) codes

    • General Medicine

    Cite this